Published in Sci Transl Med on June 30, 2010
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet (2011) 14.29
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Characterizing biobank organizations in the U.S.: results from a national survey. Genome Med (2013) 4.45
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am J Med Genet A (2011) 2.93
Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. Genome Res (2012) 2.76
Return of genomic results to research participants: the floor, the ceiling, and the choices in between. Am J Hum Genet (2014) 2.54
Practical implementation issues and challenges for biobanks in the return of individual research results. Genet Med (2012) 2.32
Experiences and attitudes of genome investigators regarding return of individual genetic test results. Genet Med (2013) 1.97
Return of individual research results and incidental findings: facing the challenges of translational science. Annu Rev Genomics Hum Genet (2013) 1.79
Informed consent and genomic incidental findings: IRB chair perspectives. J Empir Res Hum Res Ethics (2011) 1.72
Taking aims seriously: repository research and limits on the duty to return individual research findings. Genet Med (2012) 1.49
Incidental medical information in whole-exome sequencing. Pediatrics (2012) 1.48
Incomplete knowledge of the clinical context as a barrier to interpreting incidental genetic research findings. Am J Bioeth (2013) 1.48
Population biobanks and returning individual research results: mission impossible or new directions? Hum Genet (2011) 1.47
Developing a simplified consent form for biobanking. PLoS One (2010) 1.45
Disclosure of incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics (2013) 1.44
Biobanks containing clinical specimens: defining characteristics, policies, and practices. Clin Biochem (2013) 1.31
Offering aggregate results to participants in genomic research: opportunities and challenges. Genet Med (2012) 1.19
Researcher and institutional review board chair perspectives on incidental findings in genomic research. Genet Test Mol Biomarkers (2012) 1.19
Evolving approaches to the ethical management of genomic data. Trends Genet (2013) 1.18
Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting. Patient Educ Couns (2012) 1.17
Return of results: ethical and legal distinctions between research and clinical care. Am J Med Genet C Semin Med Genet (2014) 1.16
Family decision maker perspectives on the return of genetic results in biobanking research. Genet Med (2015) 1.15
Ethical and legal implications of whole genome and whole exome sequencing in African populations. BMC Med Ethics (2013) 1.14
Epilepsy patient-participants and genetic research results as "answers". J Empir Res Hum Res Ethics (2011) 1.12
Returning genetic research results: study type matters. Per Med (2013) 1.09
Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study. J Community Genet (2013) 1.05
Stem cell banking: between traceability and identifiability. Genome Med (2010) 1.04
A framework for analyzing the ethics of disclosing genetic research findings. J Law Med Ethics (2014) 1.04
The meaning of genetic research results: reflections from individuals with and without a known genetic disorder. J Empir Res Hum Res Ethics (2011) 1.03
Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations. J Law Med Ethics (2015) 1.02
An implementation framework for the feedback of individual research results and incidental findings in research. BMC Med Ethics (2014) 1.00
Processes and factors involved in decisions regarding return of incidental genomic findings in research. Genet Med (2013) 0.98
Public preferences for the return of research results in genetic research: a conjoint analysis. Genet Med (2014) 0.97
Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance. J Med Ethics (2012) 0.95
Beneficence, clinical urgency, and the return of individual research results to relatives. Am J Bioeth (2012) 0.93
Incidental findings in the era of whole genome sequencing? Hastings Cent Rep (2013) 0.93
Researchers' opinions towards the communication of results of biobank research: a survey study. Eur J Hum Genet (2011) 0.92
Views of genetics health professionals on the return of genomic results. J Genet Couns (2013) 0.91
IRB chairs' perspectives on genotype-driven research recruitment. IRB (2012) 0.91
Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting. Genet Med (2013) 0.91
Returning individual research results for genome sequences of pancreatic cancer. Genome Med (2014) 0.90
A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairs. J Genet Couns (2013) 0.88
Maternal perspectives on the return of genetic results: context matters. Am J Med Genet A (2012) 0.88
Empirical research on the ethics of genomic research. Am J Med Genet A (2013) 0.88
Feedback of research findings for vaccine trials: experiences from two malaria vaccine trials involving healthy children on the Kenyan Coast. Dev World Bioeth (2013) 0.86
Sharing individual research results with biospecimen contributors: point. Cancer Epidemiol Biomarkers Prev (2012) 0.86
Do participants in genome sequencing studies of psychiatric disorders wish to be informed of their results? A survey study. PLoS One (2014) 0.86
Flexible positions, managed hopes: the promissory bioeconomy of a whole genome sequencing cancer study. Soc Sci Med (2015) 0.85
Parents' preferences for return of results in pediatric genomic research. Public Health Genomics (2014) 0.85
Incidental genetic findings in randomized clinical trials: recommendations from the Genomics and Randomized Trials Network (GARNET). Genome Med (2013) 0.84
Online questionnaire development: using film to engage participants and then gather attitudes towards the sharing of genomic data. Soc Sci Res (2013) 0.84
The unintended implications of blurring the line between research and clinical care in a genomic age. Per Med (2014) 0.82
The Human Genome Project, and recent advances in personalized genomics. Risk Manag Healthc Policy (2015) 0.82
Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomic Research. Georgetown Law J (2014) 0.80
Using community-based participatory research principles to develop more understandable recruitment and informed consent documents in genomic research. PLoS One (2015) 0.80
Recommendations for ethical approaches to genotype-driven research recruitment. Hum Genet (2012) 0.80
Enhancing the incidental pipeline in genomic sequencing. Mol Syndromol (2014) 0.79
Disclosure of genetic research results to members of a founder population. J Genet Couns (2014) 0.78
Canadian Research Ethics Board Leadership Attitudes to the Return of Genetic Research Results to Individuals and Their Families. J Law Med Ethics (2015) 0.78
Implications of the incidentalome for clinical pharmacogenomics. Pharmacogenomics (2013) 0.78
Institutional review board perspectives on obligations to disclose genetic incidental findings to research participants. Genet Med (2015) 0.78
Genomic research with the newly dead: a crossroads for ethics and policy. J Law Med Ethics (2014) 0.78
Grappling with genomic incidental findings in the clinical realm. Chest (2014) 0.77
Utilizing Focus Groups with Potential Participants and Their Parents: An Approach to Inform Study Design in a Large Clinical Trial. AJOB Empir Bioeth (2014) 0.77
Genotype-driven recruitment: a strategy whose time has come? BMC Med Genomics (2013) 0.77
Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine. J Community Genet (2016) 0.76
To disclose, or not to disclose? Context matters. Eur J Hum Genet (2014) 0.76
Managing the Ethical Issues of Genomic Research using Pathology Specimens. Clin Biochem Rev (2015) 0.75
Disclosure of individualized research results: a precautionary approach. Account Res (2011) 0.75
Teaching health law. J Law Med Ethics (2012) 0.75
Advising patients about obtaining genomic profiles. Neurol Clin Pract (2011) 0.75
Ethical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research. Transl Vis Sci Technol (2016) 0.75
Recontacting participants for expanded uses of existing samples and data: a case study. Genet Med (2017) 0.75
Disclosing individual genetic results to research participants. Am J Bioeth (2006) 22.12
Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics (2008) 12.10
The debate over research on stored biological samples: what do sources think? Arch Intern Med (2002) 5.28
Bench to bedside: mapping the moral terrain of clinical research. Hastings Cent Rep (2008) 4.98
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol (2010) 4.93
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A (2006) 4.56
Subjects matter: a survey of public opinions about a large genetic cohort study. Genet Med (2008) 4.52
Medical researchers' ancillary clinical care responsibilities. BMJ (2004) 4.40
The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects. Hastings Cent Rep (2004) 4.39
Building and maintaining trust in a community-based participatory research partnership. Am J Public Health (2008) 3.85
The uneasy ethical and legal underpinnings of large-scale genomic biobanks. Annu Rev Genomics Hum Genet (2007) 3.30
Assessing the understanding of biobank participants. Am J Med Genet A (2009) 3.04
Tiered disclosure options promote the autonomy and well-being of research subjects. Am J Bioeth (2006) 2.69
The future of incidental findings: should they be viewed as benefits? J Law Med Ethics (2008) 2.40
Best laid plans for offering results go awry. Am J Bioeth (2006) 2.39
Undesirable implications of disclosing individual genetic results to research participants. Am J Bioeth (2006) 2.13
Prospective biorepository participants' perspectives on access to research results. J Empir Res Hum Res Ethics (2009) 1.67
Letting the gene out of the bottle: a comment on returning individual research results to participants. Am J Bioeth (2006) 1.41
International network of cancer genome projects. Nature (2010) 20.35
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA (2008) 5.25
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin (2003) 4.43
Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet (2013) 4.06
Reconsidering the family history in primary care. J Gen Intern Med (2004) 3.50
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med (2012) 3.44
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. JAMA (2006) 3.20
ASHG Statement* on direct-to-consumer genetic testing in the United States. Obstet Gynecol (2007) 3.19
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
Science and regulation. Regulating direct-to-consumer personal genome testing. Science (2010) 2.40
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
The genomic applications in practice and prevention network. Genet Med (2009) 2.39
Pharmacogenetic testing: not as simple as it seems. Genet Med (2008) 2.18
Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet (2003) 2.11
The FDA and genomic tests--getting regulation right. N Engl J Med (2015) 2.09
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med (2013) 2.08
Next-generation sequencing in the clinic: are we ready? Nat Rev Genet (2012) 1.95
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
Researcher perspectives on disclosure of incidental findings in genetic research. J Empir Res Hum Res Ethics (2010) 1.55
Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med (2008) 1.51
Clinical decisions. Screening an asymptomatic person for genetic risk. N Engl J Med (2014) 1.51
Informed Consent in Genome-Scale Research: What Do Prospective Participants Think? AJOB Prim Res (2012) 1.50
Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet Med (2010) 1.47
Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer (2008) 1.45
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med (2011) 1.44
Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med (2011) 1.36
Taking family history seriously. Ann Intern Med (2005) 1.36
Diverse perceptions of the informed consent process: implications for the recruitment and participation of diverse communities in the National Children's Study. Am J Community Psychol (2012) 1.28
Trends in death associated with pediatric dental sedation and general anesthesia. Paediatr Anaesth (2013) 1.28
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications? Genet Med (2005) 1.27
Ethical issues in identifying and recruiting participants for familial genetic research. Am J Med Genet A (2004) 1.20
Offering aggregate results to participants in genomic research: opportunities and challenges. Genet Med (2012) 1.19
An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer. Genet Med (2003) 1.18
Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genet Med (2013) 1.16
Return of results: ethical and legal distinctions between research and clinical care. Am J Med Genet C Semin Med Genet (2014) 1.16
NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer. NIH Consens State Sci Statements (2013) 1.14
Managing incidental genomic findings: legal obligations of clinicians. Genet Med (2013) 1.11
Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes. Genet Med (2007) 1.11
Educational needs in genetic medicine: primary care perspectives. Community Genet (2008) 1.09
Waiving informed consent in newborn screening research: balancing social value and respect. Am J Med Genet C Semin Med Genet (2008) 1.08
Breast cancer risk counseling improves women's functioning. Patient Educ Couns (2004) 1.06
Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med (2007) 1.06
Anticipating dissemination of cancer genomics in public health: a theoretical approach to psychosocial and behavioral challenges. Ann Behav Med (2007) 1.05
Genetics researchers' and IRB professionals' attitudes toward genetic research review: a comparative analysis. Genet Med (2012) 1.05
Does genomic risk information motivate people to change their behavior? Genome Med (2009) 1.03
Stakeholder perspectives on a risk-benefit framework for genetic testing. Public Health Genomics (2010) 0.98
Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials (2011) 0.98
Primary-care physicians' access to genetic specialists: an impediment to the routine use of genomic medicine? Genet Med (2013) 0.97
Genetic exceptionalism. Too much of a good thing? Genet Med (2008) 0.97
From leaky pipeline to irrigation system: minority education through the lens of community-based participatory research. Prog Community Health Partnersh (2012) 0.97
Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev (2005) 0.97
Genetic information: Special or not? Responses from focus groups with members of a health maintenance organization. Am J Med Genet A (2007) 0.96
Implementation outcomes of a multiinstitutional web-based ethical, legal, and social implications genetics curriculum for primary care residents in three specialties. Genet Med (2011) 0.96
Effects of individual and family functioning on interest in genetic testing. Community Genet (2004) 0.94
Effects of web-based intervention on risk reduction behaviors in melanoma survivors. J Cancer Surviv (2014) 0.94
The rules remain the same for genomic medicine: the case against "reverse genetic exceptionalism". Genet Med (2010) 0.93
Beneficence, clinical urgency, and the return of individual research results to relatives. Am J Bioeth (2012) 0.93
Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people. Am J Public Health (2013) 0.91
Cytochrome p450 enzyme polymorphism frequency in indigenous and native american populations: a systematic review. Community Genet (2008) 0.91
Health system implications of direct-to-consumer personal genome testing. Public Health Genomics (2010) 0.90
Population description and its role in the interpretation of genetic association. Hum Genet (2010) 0.90
Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study. Public Health Genomics (2009) 0.88
Maternal perspectives on the return of genetic results: context matters. Am J Med Genet A (2012) 0.88
Breast cancer risk communication: assessment of primary care physicians by standardized patients. Genet Med (2009) 0.88
Incorporating principles and practical wisdom in research ethics education: a preliminary study. Acad Med (2007) 0.87
Using pharmacogenetics to improve drug safety and efficacy. JAMA (2004) 0.85
Building partnerships in community-based participatory research: budgetary and other cost considerations. Health Promot Pract (2013) 0.85
Long-term outcomes of the "Genetics in Primary Care" faculty development initiative. Fam Med (2009) 0.84
Deliberate deceit of family members: a challenge to providers of clinical genetics services. J Clin Oncol (2006) 0.83
Achieving utility with family history: colorectal cancer risk. Am J Prev Med (2003) 0.83
Pharmacogenetic research in partnership with American Indian and Alaska Native communities. Pharmacogenomics (2014) 0.83
Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations. J Natl Cancer Inst (2002) 0.81
Familial aggregation of early-onset myocardial infarction. Community Genet (2002) 0.81
Effects of counseling Ashkenazi Jewish women about breast cancer risk. Cultur Divers Ethnic Minor Psychol (2006) 0.81
Motivating factors for physician ordering of factor V Leiden genetic tests. Arch Intern Med (2009) 0.81
Personalized medicine and tobacco-related health disparities: is there a role for genetics? Ann Fam Med (2011) 0.80
Native Hawaiian views on biobanking. J Cancer Educ (2014) 0.80
Clinical and public health implications of emerging genetic technologies. Semin Nephrol (2010) 0.80
Adding pharmacogenetics information to drug labels: lessons learned. Pharmacogenet Genomics (2006) 0.80
Use of Factor V Leiden genetic testing in practice and impact on management. Genet Med (2009) 0.79
The asthma consultative process: a collaborative approach to integrating genomics into public health practice. Prev Chronic Dis (2005) 0.79
Changing the clinical management of hereditary hemochromatosis: translating screening and early case detection strategies into clinical practice. Arch Intern Med (2004) 0.78
Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas. Pharmacogenomics (2015) 0.78
Jewish identity and intentions to obtain breast cancer screening. Cultur Divers Ethnic Minor Psychol (2003) 0.78
Duty to warn at-risk family members of genetic disease. Virtual Mentor (2009) 0.78
'That's like chopping off a finger because you're afraid it might get broken': disease and illness in women's views of prophylactic mastectomy. Soc Sci Med (2005) 0.78
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet (2016) 0.77
Hereditary hemochromatosis: perspectives of public health, medical genetics, and primary care. Genet Med (2003) 0.76
Effects of risk counseling on interest in breast cancer genetic testing for lower risk women. Genet Med (2002) 0.76
Values in translation: how asking the right questions can move translational science toward greater health impact. Clin Transl Sci (2012) 0.76
Re: On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst (2003) 0.75
Banning pens and pads misses the main point. Am J Bioeth (2003) 0.75
Breast cancer and breastfeeding. Lancet (2003) 0.75